FDA | What's New
Follow
FDA Rare Disease Framework Initiative Public Meeting - 10/28/2026
On October 28, 2026, the U.S. Food and Drug Administration, in partnership with the Reagan-Udall Foundation for the FDA, will convene a hybrid public meeting to seek input related to the FDA’s Rare Disease Framework Initiative to reimagine the agency’s approach to rare disease development.